Anesthesia and Perioperative Management of Hepatic Metastases to CRC Patients in Liver Resection. Our Experience.
Full Text PDF

Keywords

blood transfusion
CVP
CRC
liver surgery
perioperative management

How to Cite

Naço, M., Mukaj, S., Belba, M., Gani, H., Kodra, N., & Naço, E. (2020). Anesthesia and Perioperative Management of Hepatic Metastases to CRC Patients in Liver Resection. Our Experience. Albanian Journal of Trauma and Emergency Surgery, 4(1). https://doi.org/10.32391/ajtes.v4i1.81

Abstract

Background: The patients with colorectal adenocarcinoma very often developed hepatic metastases. Resection of them still remains the best treatment of disease. Hepatectomy carried about 20% mortality rate. The most important intraoperative factor is major hemorrhage and hypotension and postoperatively the main reasons are hemorrhage, coagulopathy, renal failure, pulmonary, and cardiac disturbance till biliary fistula and liver failure.  Anesthesia and perioperative management have resulted in diminished value of mortality and morbidity at the same time.

Aim: The aim of this study is to submit our experience in anesthesia and perioperative management in liver resection of hepatic metastases in CRC patients.

Material and Methods: In that retrospective study we enrolled 6 patients ASAII- III, from January to July 2019. All patients treated for liver malignancy diagnosis after colorectal carcinoma in elective surgery and received general anesthesia with fentanyl 1-2μg/kg/h, profolol 4.0μg/kg/min via target controlled infusion and vecuronium 0.001mg/kg/min and sevofluran 2%. All patients are monitored with continuous central venous pressure(CVP).  We recorded mean artery pressure (MAP), heart rate (HR), CVP, amount of transfusion, incidence of complications and discharge from intensive care and hospital.

Results: Female/male report was 66,6% vs. 33.4%. The ages of patients were 53-72 years with a mean ± SD age of 65.1 ± 9.5 years. CVP was 0-5. Amount of blood was 2.5 unite during intervention. Average of days in intensive care was 3.83. Renal compromised was 3%. Ascites and edema was 50%.  All patients were discharged home after 14.66 days.

Conclusion: Optimizing hemodynamic and fluid administration and reduced the administration of blood therapy using low CVP (0-5).

https://doi.org/10.32391/ajtes.v4i1.81
Full Text PDF

References

1. Bray F, Ferlay J, Soerjomataram I et al.Global cancer statistics 2018, Globocan estimates of incidence and mortality worldwide for 36 cancer in 185 countries, CA Cancer J Clin 2018; 68: 394–424.
2. Center MM, Jemal A, Smith RA, et al. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366–378.
3. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg. 1999;86:158–169. [PubMed] [Google Scholar]
4. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244.254-259.
5. Höhn HG. Anhang. Operationskatalog für Betriebsvergleiche (Seiten 134 - 146) Krankenhausumschau. 1985;2:134–146. [Google Scholar]
6. Andrew J , Page, David A, Kooby, Perioperative management of hepatic resection, journal of gastrointestinal Oncology, vol 3,no1, March 2012,19-28.
7. Kooby DA, Stockman J, Ben-Porat L,et al . Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003,237,860-9:
8. Francisco Carlos Bonofiglio, Anesthesia in Liver Resections: Review, Volume 8 Issue 5 – 2017. Journal of Anesthesia & Critical Care: Open Access.
9. Dunki-Jacobs EM, Philips P, Scoggins CR, McMasters KM, Martin RC (2014) Stroke volume variation in hepatic resection: A replacement for standard central venous pressure monitoring. Amn Surg Oncol 21(2): 473-478.
10. Clavien PA, Petrowsky H,& al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356;1545-59.
11. Gugenheim J, Bredt L, Iannelli A (2011) A randomized controlled trial comparing fibrin glue and plasma jet on the raw surface of the liver after hepatic resection. Hepatogastroenterology 58(107-108): 922-925.
12. Andrew Hartog, BMedSci BM BS FRCA, Anaesthesia for hepatic resection surgery . Continuing Education in Anaesthesia Critical Care & Pain, Volume 9, Issue 1, February 2009, Pages 1–5, https://doi.org/10.1093/bjaceaccp/mkn050
13. Redai I, Emond J, BrentjensT.Anesthetic considerations during liver surgery. In: Khatri VP, Schneider PD, eds. Liver Surgery: Modern Concepts and Techniques, Surgical Clinics of North America , 2004, vol. 84 (pg. 401-411).
14. Wu CC, Ho WM, Cheng SB, et al. Perioperative parenteral tranexamic acid in liver tumor resection. A prospective randomized trial toward a ‘blood transfusion’-free hepatectomy. Ann Surg , 2006, vol. 243 (173-.180)
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.